In brief
In a move that will shape global health leadership, seven individuals have been nominated to lead the World Health Organization, including former ministers and regional directors from Qatar, Saudi Arabia, Belgium, Spain, Indonesia, China, and an Armenian pediatric oncologist. The selection process will feature public forums and board interviews before WHO’s Executive Board whittles the field down to three candidates for final consideration. The World Health Assembly is scheduled to appoint the new director‑general in May 2027, with the selected person assuming office on 16 August 2027. This article outlines the nominees, the process, and the questions that remain as the global community watches the next chapter in WHO leadership.
On March 15, 2027, the World Health Organization announced that seven nominees have been put forward by its member states to fill the agency’s top position. According to Anadolu Agency, the candidates represent a broad geographical range and include former ministers, regional directors, and a pediatric oncologist. The announcement follows a series of steps designed to bring transparency, public engagement, and peer review into the selection of the next WHO director‑general.
Nominees and Their Backgrounds
The list of nominees, as reported by Anadolu Agency, showcases the diverse experience of the candidates. From Qatar, the nomination is Hanan Mohammed Al‑Kuwari, a former health minister and currently adviser to the prime minister on public health matters. The Saudi Arabian entry is Hanan Balkhy, who holds the position of WHO regional director for the Eastern Mediterranean. Belgium’s Hans Henri P. Kluge, the agency’s regional director for Europe, is also in the running.
From Spain the director‑general candidate is Maria P. Neira, who previously led WHO’s environment and health department. The Indonesian nominee is Health Minister Budi Gunadi Sadikin. China is represented by Li Song, a secretary of the All‑China Women’s Federation and a former senior health official, while the Armenian pediatric oncologist Gevorg Tamamyan, a professor and department chair at Yerevan State Medical University, has been nominated by Botswana.
Each nominee brings a blend of policy, on‑the‑ground health leadership, and academic credentials to the table. Their national appointments reflect the kind of expertise the WHO seeks in a leader capable of coordinating responses to worldwide health challenges.
Selection Process
Anadolu Agency reported that the selection process will involve two public forums and a series of executive board interviews. The first forum is slated for Nov. 18‑19 at WHO’s Geneva headquarters, where member states will have the chance to meet the nominees directly. According to the agency, the Executive Board will then narrow the field to five candidates in early 2027 before arranging interviews with those shortlisted.
After the interviews, the Board will nominate up to three finalists for consideration by the World Health Assembly. A second public forum is planned for March 15, 2027, for those finalists to make their case to the wider membership. The final decision will be made by the Assembly in May and the selected director‑general is slated to take office on 16 August 2027.
While the process appears structured, the timeline and the emphasis on public forums highlight WHO’s desire for inclusivity and accountability. The June and November forums are not routinely held for each candidacy; the agency considered them a step toward a more open selection procedure than has been typical in past decades.
WHO’s director‑general role is pivotal to setting the organization’s strategic direction, negotiating health agreements, and guiding responses to outbreaks. The upcoming selection will therefore be closely watched not only by public health professionals but also by member states, whose health priorities vary widely across the globe.
Despite the clear procedural outline, several open questions remain. The nomination process, conducted without a formal public call for candidacy, raises questions about the criteria used to shortlist candidates. Anadolu Agency notes that the WHO Executive Board has the authority to reduce the nominee pool but does not disclose the specific performance measures that will guide that decision.
Another point of uncertainty lies in the division of representation. With candidates from traditionally powerful health ministries and a single medical academic, some observers anticipate the possibility of a bias in favor of governmental experience over academic or scientific expertise. The agency’s announcement does not clarify whether the Board will prioritize representation from low‑income and middle‑income countries.
Global health leaders and civil society groups have expressed differing expectations. While many welcomed the transparent forums as a sign that WHO is addressing past criticisms of opaque appointments, others warned that the presence of high‑profile ministers might tilt the balance toward political influence.
Beyond the technicalities, the election arrives at a critical time when the WHO faces scrutiny over its handling of global disease surveillance and its coordination of international pandemic preparedness. The new director‑general will inherit a legacy of reform efforts, and the chosen candidate will set the tone for WHO’s next decade of work.
As the years march toward May 2027, the election’s final steps will involve detailed debates on each nominee’s fit and the broader strategic direction the organization aims to adopt. The upcoming public forums and board interviews are poised to bring those discussions to the forefront, ensuring the selection process reflects the diverse interests of WHO’s 194 member states. The global community will watch closely to see which of the seven nominees is ultimately selected to lead the world’s health agency into a new era.
